Dana-Farber Cancer Institute at Boston Medical Center - Brighton is a clinical research site located in Brighton, Massachusetts, United States 02135.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Dana-Farber Cancer Institute at Boston Medical Center - Brighton has participated in 18 clinical trials with 17 currently active.
Therapeutic areas: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.
Sponsors: National Cancer Institute (NCI), NRG Oncology, Alliance for Clinical Trials in Oncology.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Dana-Farber Cancer Institute at Boston Medical Center - Brighton has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana-Farber Cancer Institute at Boston Medical Center - Brighton has 18 clinical trials on record, with 17 currently active. Their work covers Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.
Yes — Dana-Farber Cancer Institute at Boston Medical Center - Brighton holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.